Non profit bodies get together to find cures for neglected diseases
This article was originally published in Scrip
Executive Summary
Two not-for-profit organisations have signed a royalty-free licence agreement that aims to speed up the development of new therapies for neglected diseases. The TB Alliance will give the Drugs for Neglected Disease initiative (DNDi) the rights to its library of TB drugs, the nitroimidazole class, to develop as potential treatments against a number of neglected tropical diseases, including visceral leishmaniasis, sleeping sickness and Chagas disease.